ALTUVOCT subst sèche 250 UI c solv flac
7680694360012
CH-69436
B02BD02
06.01.1.
Reimbursement limitations:
ALTUVOCT.01
Pour le traitement et la prophylaxie des épisodes hémorragiques chez les patients atteints d’hémophilie A …
1 / 3
google
Details
- Product number
- 6943601
- CPT
- -
- Packaging group
- -
- Unit
- 1 Durchstechflasche mit Pulver und 1 Fertigspritze mit Lösungsmittel und Zubehör
- Composition
- Praeparatio cryodesiccata: efanesoctocogum alfa 250 U.I., histidinum, arginini hydrochloridum, saccharum, calcii chloridum dihydricum, polysorbatum 80, pro vitro. Solvens: aqua ad iniectabile 3 ml.
Articles (1)
Altuvoct 250 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SOLV
|
3.0 ML | Substance | HNIDK |
|
PRC
|
250.0 UI | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 377.35
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2024
Authorization holder
Swedish Orphan Biovitrum AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 69436
- Drug name
- Altuvoct, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- B02BD02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 02/09/2024
- Authorization expiration date
- 01/09/2029
- IT number
- 06.01.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ALTUVOCT subst sèche 250 UI c solv flac
- Description (DE)
- ALTUVOCT Trockensub 250 IE c Solv Durchstf
- Market launch
- 02/09/2024
- Narcotic (BTM)
- No